Mednow Valuation
| MDNWF Stock | USD 0.02 0.00 0.00% |
Mednow seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Mednow Inc from analyzing the firm fundamentals such as Profit Margin of (1.14) %, return on equity of -1.9, and Current Valuation of 4.96 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Mednow's price fluctuation is very steady at this time. Calculation of the real value of Mednow Inc is based on 3 months time horizon. Increasing Mednow's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Mednow pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Mednow Inc. Since Mednow is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Mednow Pink Sheet. However, Mednow's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.02 | Real 0.0168 | Hype 0.02 | Naive 0.02 |
The real value of Mednow Pink Sheet, also known as its intrinsic value, is the underlying worth of Mednow Inc Company, which is reflected in its stock price. It is based on Mednow's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Mednow's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Mednow Inc helps investors to forecast how Mednow pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Mednow more accurately as focusing exclusively on Mednow's fundamentals will not take into account other important factors: Mednow Total Value Analysis
Mednow Inc is now anticipated to have takeover price of 4.96 M with market capitalization of 10.33 M, debt of 30 K, and cash on hands of 9.39 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Mednow fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.96 M | 10.33 M | 30 K | 9.39 M |
Mednow Investor Information
About 48.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.97. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mednow Inc recorded a loss per share of 0.71. The entity had not issued any dividends in recent years. Based on the key measurements obtained from Mednow's financial statements, Mednow Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Mednow Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Mednow has an asset utilization ratio of 91.76 percent. This implies that the Company is making $0.92 for each dollar of assets. An increasing asset utilization means that Mednow Inc is more efficient with each dollar of assets it utilizes for everyday operations.Mednow Ownership Allocation
Mednow Inc maintains a total of 21.57 Million outstanding shares. Mednow Inc holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Mednow Profitability Analysis
The company reported the revenue of 16.64 M. Net Loss for the year was (29.56 M) with profit before overhead, payroll, taxes, and interest of 2.78 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Mednow's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Mednow and how it compares across the competition.
About Mednow Valuation
The pink sheet valuation mechanism determines Mednow's current worth on a weekly basis. Our valuation model uses a comparative analysis of Mednow. We calculate exposure to Mednow's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Mednow's related companies.Mednow Inc., a healthcare company, develops and operates a proprietary web and mobile application to facilitate the sale and distribution of prescription medications and the delivery of virtual care, telemedicine services, and doctor home visits in Canada. The company was incorporated in 2018 and is headquartered in Vancouver, Canada. Mednow is traded on OTC Exchange in the United States.
8 Steps to conduct Mednow's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Mednow's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Mednow's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Mednow's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Mednow's revenue streams: Identify Mednow's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Mednow's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Mednow's growth potential: Evaluate Mednow's management, business model, and growth potential.
- Determine Mednow's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Mednow's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Mednow Growth Indicators
Investing in growth stocks can be very risky. If the company such as Mednow does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 21.6 M | |
| Retained Earnings | -39.3 M |
Complementary Tools for Mednow Pink Sheet analysis
When running Mednow's price analysis, check to measure Mednow's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mednow is operating at the current time. Most of Mednow's value examination focuses on studying past and present price action to predict the probability of Mednow's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mednow's price. Additionally, you may evaluate how the addition of Mednow to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |